Affinity hemodialysis for antiviral therapy with specific application to HIV

Journal of Theoretical Medicine

Volumn 4, Issue 3, 2002, Pages 157-166

  Tullis, R H ^a   Scamurra, D O ^b   Ambrus, J L ^c  

^a Aethlon Medical Inc   (United States)

^b CATHOLIC HEALTH SYSTEM   (United States)

^c UNIVERSITY AT BUFFALO   (United States)

Author keywords

Affinity hemodialysis; Clearance rate; Mathematical models; Replication rate; Virus diffusion; Virus load

Indexed keywords

AGAROSE; ANTIBODY; ANTIRETROVIRUS AGENT; COMPLEMENTARY DNA; LATEX; NUCLEIC ACID; RESIN; VIRUS PROTEIN;

ANTIBODY AFFINITY; ARTICLE; ARTIFICIAL ORGAN; CALCULATION; CELL DAMAGE; CLEARANCE; CONTROLLED STUDY; DIFFUSION; EQUIPMENT DESIGN; HEMODIALYSIS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE SYSTEM; IMMUNITY; IMMUNOAFFINITY CHROMATOGRAPHY; INFECTION CONTROL; LYMPH NODE; PREDICTION; PROTEIN FUNCTION; PROTEIN IMMOBILIZATION; PURIFICATION; REINFECTION; THEORETICAL STUDY; THERMODYNAMICS; VIRUS LOAD;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0036758275     PISSN: 10273662     EISSN: None     Source Type: Journal    
DOI: 10.1080/1027366021000041395     Document Type: Article

References (86)

1. Ahuja, T., Niaz, N., Velasco, A., Watts, B. and Paar, D. (1999) "Effects of hemodialysis and antiretroviral therapy on plasma viral load in HIV-1 infected hemodialysis patients", Clinical Nephrology 51, 40-44.
2. Ambrus, C. and Horvath, C. (1987) "Blood purification", US Patent 4,714,556.
3. Ambrus, C. and Horvath, C. (1988) "Blood purification", US Patent 4,787,974.
4. Ambrus, C., Anthone, S., Horvath, C., Kalghatgi, K., Lele, A.S., Eapen, G., Ambrus, J.L., Ryan, A.J. and Li, P. (1987) "Extracorporeal enzyme reactors for depletion of phenylalanine in phenylketonuria", Annals of Internal Medicine 106, 531-537.
5. Ameisen, J.C., Estaquier, J., Idziorek, T. and De Bels, F. (1995) "Programmed cell death and AIDS pathogenesis, significance and potential mechanisms", Current Topics in Microbiology and Immunology 200, 195-211.
6. Anker, P. (2000). "Quantitative aspects of plasma/serum DNA in cancer patients". Anker, P. and Stroun, M. (eds.) "Circulating nucleic acids in plasma or serum". Annals of the New York Academy of Science, 906 (2000) 5-7.
7. Anthone, S., Ambrus, C., Kohli, R., Anthone, R., Stadler, A., Stadler, I. and Vladutiu, A. (1995) "Treatment of aluminum overload using a cartridge with immobilized desferrioxamine", Journal of the American Society of Nephrology 6, 1271-1277.
8. Aquaro, S., Calio, R., Balestra, E., Bagnarelli, P., Cenci, A., Bertoli, A., Tavazzi, B., Di Pierro, D., Francesconi, M., Abdelahad, D. and Perno, C.F. (1998) "Clinical implications of HIV dynamics and drug resistance in macrophages", Journal of Biological Regulatory and Homeostatic Agents 12, 23-27.
9. Areson, P., Charm, S. and Wong, B.L. (1980) "Antibody affinity columns", Biotechnology and Bioengineering 22, 2207-2217.
10. Bagnarelli, P., Candela, M., Valenza, A., Manzin, A., Solforosi, L., Mazzola, F, Butini, L., Montroni, M., Gabrielli, A., Varaldo, P.E. and Clementi, M. (1997) "Dynamic features of human immunodeficiency virus type 1 (HIV-1). Viremia, kinetics of cell-free HIV-1 RNA after therapeutic plasma exchange", Journal of Infectious Disease 176, 801-804.
11. Baum, S.E., Morris, J.T., Gibbons, R.V. and Cooper, R. (1999) "Reduction in human immunodeficiency virus patient hospitalizations and nontraumatic mortality after adoption of highly active antiretroviral therapy", Military Medicine 164, 609-612.
12. Beretta, A., Clerici, M., Hasson, H., Fumagalli, L., Trabattoni, D., Lillo, F., Ferrante, P., Saniabadi, A.R., Adachi, M. and Lazzarin, A. (2000) "Ex-vivo purging of circulating monocytes results in immunovirologic improvement in partially HAART responder HIV-infected patients", Journal of Biological Regulatory and Homeostatic Agents 14, 27-31.
13. Blick, G., Scott, W.F., Crook, S.W., Buchanan, S., Garton, T., Hopkins, U., Vadaboncoeur, A.M., Doolittle, J., Bulcraig, I.A., Greiger-Zanlungo, P. and Karpas, A. (1998) "Passive immunotherapy in advanced HIV infection and therapeutic plasmapheresis in asymptomatic HIV-positive individuals, a four-year clinical experience", Biotherapy 11, 7-14.
14. Blower, S.M., Aschenbach, A.N., Gershengorn, H.B. and Kahn, J.O. (2001) "Predicting the unpredictable: Transmission of drug-resistant HIV", Nature Medicine 7, 1016-1020.
15. Bonhoeffer, S., May, R.M., Shaw, G.M. and Nowak, M.A. (1997) "Virus dynamics and drug therapy", Proceedings of the National Academy of Sciences, USA 94, 6971-6976.
16. Bourinbaiar, A.S. (1994) "The ratio of defective HIV-1 particles to replication-competent infectious virions", Acta Virologica 38, 59-61.
17. Bower, M., Fox, P., Fife, K., Gill, J., Nelson, M. and Gazzard, B. (1999) "Highly active anti-retroviral therapy (HAART) prolongs time to treatment failure in Kaposi's sarcoma", AIDS 13, 2105 -2111.
18. Bozzette, S.A. (2001) "Two studies of average life extension and HAART drug costs", New England Journal of Medicine 344, 817-831, 844-846.
19. Braunwald, E., Fauci, A.S., Kasper, D.L., Hauser, S.L., Longo, D.L. and Jameson, J.L. (2001) Harrison's Principles of Internal Medicine (McGraw-Hill, New York), 2629 pp.
20. Chaplin, J.W. (1999) "HIV pathogenesis: gpl20-antibody complexes bind CD4 and kill T4 cells-immunotoxin therapy should prevent the progression of HIV to AIDS", Medical Hypotheses 52, 133-146.
21. Chun, T. and Fauci, A. (1999) "Latent reservoirs of HIV: obstacles to the eradication of virus", Proceedings of the National Academy of Sciences, USA 96, 10958-10961.
22. Chun, T-W., Davey, Jr., R.T., Engel, D., Lane, H.C. and Fauci, A.S. (1999) "Re-emergence of HIV after stopping therapy", Nature 401, 874-875.
23. Clifford, D.B., Yiannoutsos, C., Glicksman, M., Simpson, D.M., Singer, E.J., Piliero, P.J., Marra, C.M., Francis, G.S., McArthur, J.C., Tyler, K.L., Tselis, A.C. and Hyslop, N.E. (1999) "HAART improves prognosis in HIV-associated progressive multifocal leukoencephalopathy", Neurology 52, 623-625.
24. Cloyd, M.W., Chen, J.J. and Wang, I. (2000) "How does HIV cause AIDS? The homing theory", Molecular Medicine Today 6, 108-111.
25. Cohen, J. (2001) Shots in the Dark. The Wayward Search for an AIDS Vaccine (W.W. Norton and Co., New York), 384 pp.
26. Cohen, O.J., Kinter, A. and Fauci, A.S. (1997) "Host factors in the pathogenesis of HIV disease", Immunology Reviews 159, 31-48.
27. Cuatracasas, P., Wilchek, M. and Anfinsen, C.B. (1968) "Selective enzyme purification by affinity chromatography", Proceedings of the National Academy of Sciences, USA 61, 636-643.
28. Cussler, E. (1998) Diffusion: Mass Transfer in Fluid Systems (Cambridge University Press, Cambridge).
29. Davis, P. (1998) "FDA researchers model virus transport through synthetic barriers", Society for Industrial and Applied Mathematics News, 31.
30. Fauci, A.S., Pantaleo, G., Stanley, S. and Weissman, D. (1996) "Immunopathogenic mechanisms of HIV infection", Annals of Internal Medicine 124, 654-663.
31. Fauci, A.S., Bartlett, J.G., Goosby, E.P., Kates, J. (2001). "Guidelines for the Use of Antiretroviral Agents in HIV-Infected Adults and Adolescents, February 2001". Panel on Clinical Practices for Treatment of HIV Infection, Department of Health and Human Services (DHHS), http://www.hivatis.org
32. Ferre, F., Moss, R.B., Daigle, A., Richieri, S.P., Jensen, F. and Carlo, D.J. (1995) "Viral load in peripheral blood mononuclear cells as surrogate for clinical progression", Journal of Acquired Immunodeficiency Syndrome and Human Retrovirology 10, S51-S56.
33. Furst, D., Felson, D., Thoren, G. and Gendreau, R.M. (2000) "Immunoadsorption for the treatment of rheumatoid arthritis: final results of a randomized trial. Prosorba Trial Investigators", Therapeutic Apheresis 4, 363-373.
34. Furtado, M.R., Callaway, D.S., Phair, J.P., Kunstman, K.J., Stanton, J.L., Macken, C.A., Perelson, A.S. and Wolinsky, S.M. (1999) "Persistence of HIV-1 transcription in peripheral-blood mononuclear cells in patients receiving potent antiretroviral therapy", New England Journal of Medicine 340(21), 1614-1622.
35. Gallo, R.C. and Schupbach, J. (2000) "Human retroviruses", In: Specter, S., Hodinka, R.L. and Young, S.A., eds, Clinical Virology Manual (ASM Press, Washington, DC), pp 513-549.
36. Gray, F., Adle-Biassette, H., Chretien, F., Lorin de la Grandmaison, G., Force, G. and Keohane, C. (2001) "Neuropathology and neurodegeneration in human immunodeficiency virus infection. Pathogenesis of HIV-induced lesions of the brain, correlations with HIV-associated disorders and modifications according to treatments", Clinical Neuropathology 20, 146-155.
37. Hauswirth, W., Lewin, A., Zolotukhin, S. and Muzyczka, N. (2000) "Production and purification of recombinant adeno-associated virus", Methods in Enzymology 316, 743-761.
38. Ho, D.D. (1995) "HIV-1 dynamics in vivo", Journal of Biological Regulatory and Homeostatic Agents 9, 76-77.
39. Ho, D.D., Neumann, A.U., Perelson, A.S., Chen, W., Leonard, J.M. and Markowitz, M. (1995) "Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection", Nature 373, 123-126.
40. Jardine, D.K., Tyssen, D.P. and Birch, C.J. (2000) "Effect of protease inhibitors on HIV-1 maturation and infectivity", Antiviral Research 45, 59-68.
41. Kameoka, M., Kimura, T., Zheng, Y.H., Suzuki, S., Fujinaga, K., Luftig, R.B. and Ikuta, K. (1997a) "Protease-defective, gp120-containing human immunodeficiency virus type 1 particles induce apoptosis more efficiently than does wild-type virus or recombinant gp120 protein in healthy donor-derived peripheral blood T cells", Journal of Clinical Microbiology 35, 41-47.
42. Kameoka, M., Suzuki, S., Kimura, T., Fujinaga, K., Auwanit, W., Luftig, R.B. and Ikuta, K. (1997b) "Exposure of resting peripheral blood T cells to HIV-1 particles generates CD25+ killer cells in a small subset, leading to induction of apoptosis in bystander cells", International Immunology 9, 1453 -1462.
43. Kapadvanjwala, M. and Sofer, S. (1989) "A mathematical simulation of the AIDS patient and extracorporeal detoxification", Computers in Biology and Medicine 19, 461-470.
44. Kilby, J.M., Hopkins, S., Venetta, T.M., DiMassimo, B., Cloud, G.A., Lee, J.Y., Alldredge, L., Hunter, E., Lambert, D., Bolognesi, D., Matthews, T., Johnson, M.R., Nowak, M.A., Shaw, G.M. and Saag, M.S. (1998) "Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry", Nature Medicine 4, 1302-1307.
45. Kiprov, D.D., Kwiatkowska, B.J. and Miller, R.G. (1990) "Therapeutic apheresis in human immunodeficiency virus-related syndromes", Current Studies in Hematology and Blood Transfusion 57, 184-197.
46. Koga, Y. (1996) "Apoptosis induction and its mechanism in HIV infection", Nippon Rinsho 54, 1842-1847.
47. Krucker, T., Toggas, S.M., Mucke, L. and Siggins, G.R. (1998) "Transgenic mice with cerebral expression of human immunodeficiency virus type-1 coat protein gp120 show divergent changes in short- and long-term potentiation in CA1 hippocampus", Neuroscience 83, 691-700.
48. Kulkosky, J., Bouhamdan, M., Geist, A., Nunnari, G., Phinney, D.G. and Pomerantz, R.J. (2000) "Pathogenesis of HIV-1 infection within bone marrow cells", Leukemia and Lymphoma 37, 497-515.
49. Lafeuillade, A., Djediouane, A., Poggi, C., Profizi, N., Costes, O. and Tamalet, C. (1996a) "Kinetics of viral clearance in plasma, peripheral blood mononuclear cells and lymph nodes", AIDS 10, 801-802.
50. Lafeuillade, A., Poggi, C., Profizi, N., Tamalet, C. and Costes, O. (1996b) "Human immunodeficiency virus type 1 kinetics in lymph nodes compared with plasma", Journal of Infectious Diseases 174, 404-407.
51. Lawrence, J.E. (1993) "Affinity chromatography to remove viruses during preparation of plasma derivatives", Development of Biological Standards 81, 191-197.
52. Layne, S.P., Merges, M.J., Dembo, M., Sponge, J.L., Conley, S.R., Moore, J.P., Raina, J.L., Renz, H., Gelderblom, H.R. and Nara, P.L. (1992) "Factors underlying spontaneous inactivation and susceptibility to neutralization of human immunodeficiency virus", Virology 189, 695-714.
53. Lipton, S. (1998) "Neuronal injury associated with HIV-1. Approaches to treatment", Annual Reviews of Pharmacology and Toxicology 38, 159-177.
54. Little, S.J., McLean, A.R., Spina, C.A., Richman, D.D. and Havlir, D.V. (1999) "Viral dynamics of acute HIV-1 infection", Journal of Experimental Medicine 190, 841-850.
55. Lopukhin Iu, M., Pavlenko, V.V., Kulaev, D.V., Liukova, T.K., Petrunin, D.D., Karamov, E.V. and Rudneva, I.A. (1991) "Immunosorption of individual HIV proteins and virions", Vestnik Akademii Meditsinskikh Nauk SSSR 11, 60-63.
56. Lopukhin Iu, M., Pavlenko, V.V., Kulaev, D.V., Alekseichuk, V.S., Karamov, E.V., Rudneva, I.A., Petrunin, D.D. and Liukova, T.K. (1992) "Possibility of selective binding of HIV-1 infected cells by immunosorbents", Vestnik Rossiiskoi Akademii Meditsinskikh Nauk 3, 54-56.
57. i and the toxic actions of the HIV coat protein GP120", European Journal of Neuroscience 11(4), 1167-1178.
58. Meinkoth, J. and Wahl, G. (1984) "Hybridization of nucleic acids immobilized on solid supports", Analytical Biochemistry 138, 267-284.
59. Menzo, S., Bagnarelli, P., Monachetti, A., Fiorelli, L. and Clementi, M. (2000) "Complexity and dynamics of HIV-1 quasispecies", Journal of Biological Regulatory and Homeostatic Agents 14, 4-6.
60. Mocroft, A., Madge, S., Johnson, A.M., Lazzarin, A., Clumeck, N., Goebel, F.D., Viard, J.P., Gatell, J., Blaxhult, A. and Lundgren, J.D. (1999) "A comparison of exposure groups in the EuroSIDA study: starting highly active antiretroviral therapy (HAART), response to HAART, and survival", Journal of Acquired Immunodeficieny Syndrome 22, 369-378.
61. Motomura, T., Miyashita, Y., Ohwada, T., Onishi, M. and Yamamoto, N. (1997). "Material for removing HIV and its related substances". US Patent 5,667,684.
62. Muller, S. and Kohler, H. (1997) "B cell superantigens in HIV-1 infection", International Reviews in Immunology 14(4), 339-349.
63. Nair, M.P., Pottathil, R., Heimer, E.P. and Schwartz, S.A. (1988) "Immunoregulatory activities of human immunodeficiency virus (HIV) proteins: effect of HIV recombinant and synthetic peptides on immunoglobulin synthesis and proliferative responses by normal lymphocytes", Proceedings of the National Academy of Sciences, USA 85, 6498-6502.
64. Neumann, A.U., Tubiana, R., Calvez, V., Robert, C., Li, T.S., Agut, H., Autran, B. and Katlama, C. (1999) "HIV-1 rebound during interruption of highly active antiretroviral therapy has no deleterious effect on reinitiated treatment. Comet Study Group", AIDS 13, 677-683.
65. Nygren, H., Werthen, M. and Stenberg, M. (1987) "Kinetics of antibody binding to solid-phase-immobilised antigen. Effect of diffusion rate limitation and steric interaction", Journal of Immunological Methods 101, 63-71.
66. O'Brien, W.A., Hartigan, P.M., Martin, D., Esinhart, J., Hill, A., Benoit, S., Rubin, M., Simberkoff, M.S. and Hamilton, J.D. (1996) "Changes in plasma HIV-1 RNA and CD4+ lymphocyte counts and the risk of progression to AIDS. Veterans Affairs Cooperative Study Group on AIDS", New England Journal of Medicine 334, 426-431.
67. Ogg, G.S., Jin, X., Bonhoeffer, S., Dunbar, P.R., Nowak, M.A., Monard, S., Segal, J.P., Cao, Y., Rowland-Jones, S.L., Cerundolo, V., Hurley, A., Markowitz, M., Ho, D.D., Nixon, D.F. and McMichael, A.J. (1998) "Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA", Science 279, 2103-2106.
68. Pearce-Pratt, R. and Phillips, D.M. (1993) "Studies of adhesion of lymphocytic cells: implications for sexual transmission of human immunodeficiency virus", Biology of Reproduction 48(3), 431-445.
69. Ramratnam, B., Bonhoeffer, S., Binley, J., Hurley, A., Zhang, L., Mittler, J.E., Markowitz, M., Moore, J.P., Perelson, A.S. and Ho, D.D. (1999) "Rapid production and clearance of HIV-1 and hepatitis C virus assessed by large volume plasma apheresis", Lancet 354, 1782-1785.
70. Ramratnam, B., Mittler, J.E., Zhang, L., Boden, D., Hurley, A., Fang, F., Macken, C.A., Perelson, A.S., Markowitz, M. and Ho, D.D. (2000) "The decay of the latent reservoir of replication-competent HIV-1 is inversely correlated with the extent of residual viral replication during prolonged anti-retroviral therapy", Nature Medicine 6, 82-85.
71. Saha, D. and Agarwal, S. (2001) "Hepatitis and HIV infection during haemodialysis", Journal of the Indian Medical Association 99(4), 194-202.
72. Scamurra, D., Ambrus, J. (1999). "Method for removal of HIV and other viruses". US Patent Application 60/098,477; PCT/US 99-19448.
73. Schnittman, S.M., Lane, H., Higgins, S.E., Folks, T. and Fauci, A. (1986) "Direct polyclonal activation of human B-lymphocytes by the acquired immune deficiency syndrome virus", Science 233(4786), 1094-1086.
74. Schnittman, S.M., Psallidopoulos, M.C., Lane, H.C., Thompson, L., Baseler, M., Massari, F., Fox, C.H., Salzman, N.P. and Fauci, A.S. (1989) "The reservoir for HIV-1 in human peripheral blood is a T cell that maintains expression of CD4", Science 245, 305-308.
75. Stafford, M.A., Corey, L., Cao, Y., Daar, E.S., Ho, D.D. and Perelson, A.S. (2000) "Modeling plasma virus concentration during primary HIV infection", Journal of Theoretical Biology 203, 285-301.
76. Su, Q., Wang, S.F., Chang, T.E., Breitkreutz, R., Hennig, H., Takegoshi, K., Edler, L. and Schroder, C.H. (2001) "Circulating hepatitis B virus nucleic acids in chronic infection: representation of differently polyadenylated viral transcripts during progression to nonreplicative stages", Clinical Cancer Research 7(7), 2005-2015.
77. Takashima, S.K., Keiichi, N., Nakaji, S., Yamane, K., Murayama, R. (1991). "Method for removing human immunodeficiency virus and/or its related compounds". US Patent 5,041,079.
78. Tepic, S., Laissue, J.A. (1996). "An extracorporeal blood treatment apparatus and method for removal of free circulating infectious agents based on immobilized CD4 receptors". Patent Application WO96 28198.
79. Terman, D. S., Sulliva, M., Cullis, H.M. (1980). "Apparatus for the extracorporeal treatment of disease". US Patent 4,215,688.
80. Tuckwell, H.C. and Le Corfec, E. (1998) "A stochastic model for early HIV-1 population dynamics", Journal of Theoretical Biology 195, 451-463.
81. Wang, H., Tsao, I. (1988). "Cellular receptor adsorbents for removal of viral contaminants from blood and complex protein solutions". Patent Application WO8901813A1.
82. Wei, X., Ghosh, S.K., Taylor, M.E., Johnson, V.A., Emini, E.A., Deutsch, P., Lifson, J.D., Bonhoeffer, S., Nowak, M.A. and Hahn, B.e.a. (1995) "Viral dynamics in human immunodeficiency virus type 1 infection", Nature 373, 117-122.
83. Wiegers, K., Rutter, G., Kottler, H., Tessmer, U., Hohenberg, H. and Krausslich, H.G. (1998) "Sequential steps in human immunodeficiency virus particle maturation revealed by alterations of individual Gag polyprotein cleavage sites", Journal of Virology 72, 2846-2854.
84. Winston, J. and Klotman, P.E. (1998) "HIV-associated nephropathy", Mount Sinai Journal of Medicine 65, 27-32.
85. Wodarz, D., Lloyd, A.L., Jansen, V.A. and Nowak, M.A. (1999) "Dynamics of macrophage and T cell infection by HIV", Journal of Theoretical Biology 196, 101-113.
86. Zhang, L., Ramratnam, B., Tenner-Racz, K., He, Y., Vesanen, M., Lewin, S., Talal, A., Racz, P., Perelson, A.S., Korber, B.T., Markowitz, M. and Ho, D.D. (1999) "Quantifying residual HIV-1 replication in patients receiving combination antiretroviral therapy", New England Journal of Medicine 340, 1605-1613.